A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes

Summary

It is a phase II, randomized, double-blind, placebo-controlled study of P2202 in patients of type 2 diabetes mellitus, inadequately controlled with a stable dose of metformin or sulfonylurea or both.

Timeline

Start

2011-04

Primary completion

2012-12

Completion

2013-07

Outcome

Outcome not reported

Stopped (Enrollment): “Due to non-recruitment, the study is being halted. There are no major safety or tolerability concerns in the study conducted so far.”

Drugs

Indications